Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2010
11/04/2010US20100279973 Synthesis of purine nucleosides
11/04/2010US20100279969 Azido purine nucleosides for treatment of viral infections
11/04/2010US20100279968 Mutagenic Nucleoside Analogs for the Treatment of Viral Disease
11/04/2010US20100279959 Medium-Chain Length Fatty Acids, Glycerides and Analogues as Neutrophil Survival and Activation Factors
11/04/2010US20100279958 Compounds and methods for inhibiting selectin-mediated function
11/04/2010US20100279924 Peptides and peptide derivatives as well as pharmaceutical compositions containing the same
11/04/2010US20100279861 Antifungal Agents
11/04/2010US20100279406 Alteration of tumor growth using zinc finger proteins
11/04/2010US20100278945 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
11/04/2010US20100278943 Anti viral composition
11/04/2010US20100278941 Enhanced erythropoiesis and iron metabolism
11/04/2010US20100278936 Composition for treating skin lesions
11/04/2010US20100278935 Immune System Modulator Formulation
11/04/2010US20100278929 Antibody formulations having optimized aggregation and fragmentation profiles
11/04/2010US20100278923 Functional nanoparticle-based antibiotics and preparation method thereof
11/04/2010US20100278919 Dendritic cell targeting compositions and uses thereof
11/04/2010US20100278918 Extended release formulation of nevirapine
11/04/2010US20100278915 Compositions comprising an antihistamine, antitussive and decongestant in extended release formulations
11/04/2010US20100278907 Immunogenic Compositions Containing Ceramide and Methods of Use Thereof
11/04/2010US20100278901 Compositions and methods of making rapidly dissolving ionically masked formulations
11/04/2010US20100278900 Chlorine dioxide based gum and candy
11/04/2010US20100278895 Antioxidants and antimicrobial accessories including antioxidants
11/04/2010US20100278894 Antioxidants and antimicrobial accessories including antioxidants
11/04/2010US20100278892 High affinity metal-oxide binding peptides with reversible binding
11/04/2010US20100278885 C70-Containing Liposome, Method for Producing the Same, and Use of the Same
11/04/2010US20100278868 Codon-Optimized Dna Molecules Encoding the Receptor Binding Domains of Clostridium Difficile Toxins A and B, and Methods of Use Thereof
11/04/2010US20100278866 Borrelia diagnostics and screening methods
11/04/2010US20100278865 Production and use of epitope-tagged hepatitis c virus particle
11/04/2010US20100278864 Rabies Vaccine
11/04/2010US20100278862 Nipah Virus Vaccines
11/04/2010US20100278861 Methods and compositions for predicting emergence and expansion of drug resistant strains of influenza virus
11/04/2010US20100278860 System and method for identifying complex patterns of amino acids
11/04/2010US20100278859 Diagnostic test kits
11/04/2010US20100278858 Process for preparing attenuated viral strains
11/04/2010US20100278857 Dendritic Cell Binding Proteins and Uses Thereof
11/04/2010US20100278854 Chlamydia antigens
11/04/2010US20100278853 Constrained hiv v3 loop peptides as novel immunogens and receptor antagonists
11/04/2010US20100278852 Antibodies against and methods for producing vaccines for respiratory syncytial virus
11/04/2010US20100278841 DOWN-REGULATION OF MORTALIN BY siRNA
11/04/2010US20100278835 Novel compounds 660
11/04/2010US20100278834 Antibodies against h5n1 strains of influenza a virus
11/04/2010US20100278830 Methods and systems for multi-antibody therapies
11/04/2010US20100278819 Streptococcus pneumoniae vaccines
11/04/2010US20100278813 Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies
11/04/2010US20100278776 Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof
11/04/2010US20100278773 Chimeric flavivirus vaccines
11/04/2010US20100278765 Regulation of mammalian keratinous tissue using hexamidine compositions
11/04/2010US20100278759 Topical Therapeutic Delivery System
11/04/2010US20100278742 Methods and compositions for detection and diagnosis of infectious diseases
11/04/2010US20100278740 Streptococcus pneumoniae proteins and nucleic acid molecules
11/04/2010US20100278727 Alpha-Emitting constructs and uses thereof
11/04/2010US20100278725 Methods and devices for lymphatic targeting
11/04/2010DE102009019104A1 Kosmetische oder dermatologische Zusammensetzung enthaltend Hydrolysate aus Pflanzenextrakten Cosmetic or dermatological composition containing hydrolysates of plant extracts
11/04/2010CA2760591A1 Cleanser compositions and methods for using the same
11/04/2010CA2760589A1 Treatment of hemoglobin (hbf/hbg) related diseases by inhibition of natural antisense transcript to hbf/hbg
11/04/2010CA2760526A1 Antimicrobial agents
11/04/2010CA2760525A1 Toll-like receptor 3 antagonists
11/04/2010CA2760392A1 Influenza vaccine
11/04/2010CA2760325A1 Inactivated bacterial cell formulation
11/04/2010CA2760098A1 Mutants of francisella tularensis and uses thereof
11/04/2010CA2760096A1 Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
11/04/2010CA2759989A1 Anti cxcr4 antibodies for the treatment of hiv
11/04/2010CA2759476A1 Novel compounds
11/04/2010CA2759400A1 Chimeric factor h binding proteins (fhbp) and methods of use
11/04/2010CA2756760A1 Compositions and methods for screening and using compounds antagonizing spore-surface interactions
11/04/2010CA2756442A1 Site-directed pegylation of arginases and the use thereof as anti-cancer and anti-viral agents
11/03/2010EP2246367A1 Low-molecular-weight substance derived from maitake mushroom and having immunostimulating activity and anti-tumor activity
11/03/2010EP2246364A1 Anti CXCR4 antibodies for the treatment of HIV
11/03/2010EP2246361A1 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
11/03/2010EP2246358A1 Oligonucleotides against HIV infection and its application in the prevention and treatment of acquired immune deficiency syndrome
11/03/2010EP2246357A1 Oligonucleotides against HIV infection and its application in the prevention and treatment of acquired immune deficiency syndrome
11/03/2010EP2246349A1 Treatment of infectious diseases
11/03/2010EP2246332A1 Pyrazole derivatives as anti-francisella agents
11/03/2010EP2245047A1 Hydrophobic modified pres-derived peptides of hepatitis b virus (hbv) and their use as vehicles for the specific delivery of compounds to the liver
11/03/2010EP2245045A1 Peptide derivatives useful in the treatment, care or cleansing of the skin, mucosae, scalp or nails
11/03/2010EP2245028A1 5-aminocyclylmethyl-oxazolidin-2-one derivatives
11/03/2010EP2245027A1 Hepatitis c virus inhibitors
11/03/2010EP2245023A1 Heterocyclic antiviral compounds
11/03/2010EP2245015A1 Difluorinated tripeptides as hcv serine protease inhibitors
11/03/2010EP2244999A1 Antimicrobial surfaces
11/03/2010EP2244695A1 Compositions for inducing immune responses
11/03/2010EP2136807B1 Pyrrolo (3, 2, 1-ij) quinoline-4-one derivatives for treating tuberculosis
11/03/2010EP2029556B1 Salts and crystal modifications thereof
11/03/2010EP1970372B1 Salts of 9-oxoacridine-10-acetic acid with 1-alkylamno-1-desoxy-polyols
11/03/2010EP1855695B1 Solid pharmaceutical composition comprising telithromycin
11/03/2010EP1660511B1 Novel tricyclic nucleosides or nucleotides as therapeutic agents
11/03/2010EP1617858B1 Caspase 3, 8, 9 or 10 inhibitors in combination with MEK inhibitors for the treatment of influenza
11/03/2010EP1599496B1 Hepatitis c inhibitor peptide analogs
11/03/2010EP1404302B1 Pharmaceutical compositions comprising adsorbates of amorphous drug
11/03/2010EP1296929B1 Modified forms of pharmacologically active agents and uses therefor
11/03/2010EP1242437B1 Novel stromelysin inhibitors
11/03/2010EP1076662B1 Polyepitope carrier protein
11/03/2010EP0719273B1 Nucleotide analogs
11/03/2010CN1951390B Pharmaceutical compositions comprising colloidal silicon dioxide
11/03/2010CN1927303B Chinese medicine for treating chicken respiratory tract disease
11/03/2010CN1895667B Reovirus inactivated vaccine and its preparation
11/03/2010CN1879736B Antibacterial Chinese medicinal composition for birds and preparation method thereof
11/03/2010CN1872076B Drop pills of cucurbitacine, and preparation method
11/03/2010CN1872075B Drop pills of hemsleyadin, and preparation method
11/03/2010CN1872059B Drop pills of matrine, and preparation method
1 ... 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 ... 1798